Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
AcelRx Pharmaceuticals, Inc.

AcelRx Pharmaceuticals, Inc. (ACRX) Stock Overview

Explore AcelRx Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.

ACRX●NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$0.86
$0.06(7.50%)
U.S. Market is Open · 13:56

AcelRx Pharmaceuticals, Inc. (ACRX)

Meyka AI Score

Z

Key Financials

Market Cap14.6M
P/E Ratio-3.07
EPS (TTM)$-2.75
ROE-0.93%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

ACRX Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, AcelRx Pharmaceuticals, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of ACRX on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind AcelRx Pharmaceuticals, Inc.'s NASDAQ-traded stock include a P/E ratio of -3.07 and a market capitalization of 14.6M. Combined with our AI analysis, these give both institutional and retail investors a clear view of ACRX on the NASDAQ.

Price Performance (NASDAQ: ACRX)

1-Day Change
N/A
5-Day Change
-18.10%
1-Month Change
7.50%
3-Month Change
62.23%
6-Month Change
-9.47%
Year-to-Date (YTD) Change
16.15%
1-Year Change
-55.67%
3-Year Change
-98.34%
5-Year Change
-98.29%
All-Time (Max) Change
-99.05%

Contact Information

https://talphera.com
650 216 3500
25821 Industrial Boulevard, Hayward, CA, 94545

Company Facts

190 Employees
IPO DateFeb 11, 2011
CountryUS

Frequently Asked Questions